ID
40561
Beschreibung
ADVANCED PROSTATE CANCER DATA COLLECTION Version 2.3.1 Revised: April 10th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement (www.ICHOM.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. Conditions: All patients with advanced prostate cancer, either having metastatic disease or biochemical recurrence progressing after salvage treatment or ineligible for salvage treatment. Patients with biochemical recurrence treated with salvage therapy are referred to the localized prostate cancer set. Treatment Approaches: Hormonal Therapy | Chemotherapy | Immunotherapy | Radiopharmaceuticals | Radiation | Interventions for Complications of Local Progression This form contains patient-reported outcome variables. To be assessed 6 months and 1 year post (initial) treatment and annually for life from then on. Questionnaires used in this form: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC‐CP rather than the EPIC‐26, we recommend using the same variable IDs as the corresponding EPIC‐26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed (according to ICHOM). Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): For use of the EORTC QLQ-C30 a license is needed, therefore the questions will not be part of this version of the standard set. (eortc.be) The following paper has been published about development of this standard set: Morgans AK, van Bommel ACM, Stowell C, Abrahm JL, Basch E, Bekelman JE, et al. Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach. Eur Urol. 2015 Nov;68(5):891–8. For the standard set ICHOM has been supported by the Movember Foundation. For this version of the standard set, semantic annotation with UMLS CUIs has been added.
Link
Stichworte
Versionen (2)
- 29.11.18 29.11.18 - Sarah Riepenhausen
- 30.04.20 30.04.20 - Sarah Riepenhausen
Rechteinhaber
ICHOM
Hochgeladen am
30. April 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
ICHOM Advanced Prostate Cancer
Follow-Up Patient-reported Form
- StudyEvent: ODM
Beschreibung
Degree of health
Alias
- UMLS CUI-1
- C0018759
Beschreibung
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0002771
- UMLS CUI [1,2]
- C1298908
Beschreibung
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0002771
- UMLS CUI [1,2]
- C2709201
- UMLS CUI [2,1]
- C0002771
- UMLS CUI [2,2]
- C0013231
Beschreibung
Over the counter pain medicine is for example paracetamol, NSAIDS INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Multiple answer
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0002771
- UMLS CUI [1,2]
- C0304227
- UMLS CUI [2]
- C0027409
- UMLS CUI [3]
- C0002772
Beschreibung
As a license is needed for use of this questionnaire, the 30 actual questions are not included in this version of the standard set. ICHOM IDs are EORTCQLQC30_Q01 up to EORTCQLQC30_Q30. INCLUSION CRITERIA: All patients TIMING: Baseline, 30 days + annually up to 5 years after index event REPORTING SOURCE: Patient-reported TYPE: Numerical (each question is single answer in original set)
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C4055104
- UMLS CUI [1,2]
- C2964552
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289637
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289645
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289630
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289641
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289629
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289644
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289625
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289626
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289631
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289627
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289636
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289634
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4287870
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289649
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289633
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289647
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289646
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289628
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289639
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289648
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289632
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289638
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289643
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289640
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289635
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C4289642
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C3899191
Beschreibung
INCLUSION CRITERIA: All patients TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C3827672
Beschreibung
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C0663448
Beschreibung
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C2366566
Beschreibung
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C3828613
Beschreibung
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C3827672
Beschreibung
INCLUSION CRITERIA: All patients, If answered 'yes' to using medications or devices to aid or improve erections (LIBID_Q02) TIMING: Baseline, 3 months post initiation of treatment, 6 months post initiation of treatment, 1 year post initiation of treatment, Tracked ongoing annually for life REPORTING SOURCE: Patient-reported TYPE: Single answer
Datentyp
integer
Alias
- UMLS CUI [1]
- C1115771
Ähnliche Modelle
Follow-Up Patient-reported Form
- StudyEvent: ODM
C1442488 (UMLS CUI [1,2])
C1298908 (UMLS CUI [1,2])
C2709201 (UMLS CUI [1,2])
C0002771 (UMLS CUI [2,1])
C0013231 (UMLS CUI [2,2])
C0304227 (UMLS CUI [1,2])
C0027409 (UMLS CUI [2])
C0002772 (UMLS CUI [3])
C2964552 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C0558293 (UMLS CUI-2)
(Comment:en)
(Comment:en)
C2003901 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0549184 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0549184 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
C0442811 (UMLS CUI-2)
(Comment:en)
C0700321 (UMLS CUI-2)
(Comment:en)
C0205081 (UMLS CUI-2)
(Comment:en)
C1298908 (UMLS CUI-2)
(Comment:en)
C0549177 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)